Nursing and Clinical Care Services at CHOP prepare to begin virtual reality programming to provide advanced education for staff.

CHOP's Center for Outcomes in REsearch in Surgery (CORES) is making strides to improve outcomes for children with surgical conditions. The Center, led by attending urologist Gregory E. Tasian, MD, MSCE, breaks down clinical and research silos and groups researchers with patient families to improve our ability to apply outcomes back into care.

CHOP Chief Scientific Officer Susan Furth, MD, PhD, and PEDSnet founder Christopher B. Forrest, MD, PhD have been elected to the National Academy of Medicine.

Karl F. Godlewski, MD, recently joined our attending team following his completion of a two-year fellowship with our Division. Dr. Godlewski has special interest in hypospadias and bladder exstrophy, and he has extensive experience in all areas of pediatric urology, including robotics — both typical and complex.

CHOP Attending Pediatric Urologist Christopher Long, MD, joined three international faculty to lead a live surgical course on hypospadias in Johannesburg, South Africa.

Ten years ago, we became one of the first institutions to standardize clinical documentation and collect granular data on penile biometrics, operative surgical details, and postoperative outcomes for all patients, which has allowed us to evaluate our outcomes and advance treatment strategies. We are now reaping the rewards.

Correction of chordee or penile curvature is widely considered the rate limiting step in determining whether hypospadias can be corrected in one or two stages regardless of the initial presentation of the meatal location.

We have developed a unique hypospadias database that is fully integrated into our EPIC electronic medical record. It allows us to keep a close monitor on our surgical patients and will help us drive down complications after complex hypospadias surgery.

CHOP researchers have developed a computational tool to determine which cells in patient tumor samples receive mitochondria from T cells.

Antibiotic use in neonatal intensive care units (NICUs) decreased substantially over the past decade, according to CHOP researchers.